SPOTLIGHT -
Atomoxetine displays long-term efficacy in adult patients with ADHD
Long-term treatment of 384 adults ADHD patients with atomoxetine (Strattera, Lilly) showed that 67% responded with at least a 30% improvement and 40% had at least a 50% improvement.
Methylphenidate-MAOI contraindication.
New contraindications and precautions have been added to the labeling of methylphenidate HCl tablets (Ritalin and Ritalin-SR, Novartis)-approved for treatment of attention deficit/hyperactivity disorder (ADHD).
AccuNeb (Albuterol sulfate inhalation solution) DuoNeb (Albuterol sulfate and ipratropium bromide inhalation solution) Dey
New Formulations/Combinations: Pediatric-specific albuterol formulation; fixed-dose bronchodilator combination
Epivir-HBV (Lamivudine tablets and oral solution) GlaxoSmithKline
New Indication: Hepatitis B indication expanded to pediatric patients
